Hepatic ER&#945; accounts for sex differences in the ability to cope with an excess of dietary lipids by C. Meda et al.
Original ArticleHepatic ERa accounts for sex differences in the
ability to cope with an excess of dietary lipidsClara Meda 1, Mara Barone 2,3, Nico Mitro 4, Federica Lolli 4, Silvia Pedretti 4, Donatella Caruso 4,
Adriana Maggi 2,3, Sara Della Torre 2,3,*ABSTRACT
Objective: Among obesity-associated metabolic diseases, non-alcoholic fatty liver disease (NAFLD) represents an increasing public health issue
due to its emerging association with atherogenic dyslipidemia and cardiovascular diseases (CVDs). The lower prevalence of NAFLD in pre-
menopausal women compared with men or post-menopausal women led us to hypothesize that the female-inherent ability to counteract this
pathology might strongly rely on estrogen signaling.
In female mammals, estrogen receptor alpha (ERa) is highly expressed in the liver, where it acts as a sensor of the nutritional status and adapts
the metabolism to the reproductive needs. As in the male liver this receptor is little expressed, we here hypothesize that hepatic ERa might
account for sex differences in the ability of males and females to cope with an excess of dietary lipids and counteract the accumulation of lipids in
the liver.
Methods: Through liver metabolomics and transcriptomics we analyzed the relevance of hepatic ERa in the metabolic response of males and
females to a diet highly enriched in fats (HFD) as a model of diet-induced obesity.
Results: The study shows that the hepatic ERa strongly contributes to the sex-speciﬁc response to an HFD and its action accounts for opposite
consequences for hepatic health in males and females.
Conclusion: This study identiﬁed hepatic ERa as a novel target for the design of sex-speciﬁc therapies against fatty liver and its cardio-metabolic
consequences.
 2019 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In female mammals, liver estrogen receptor alpha (ERa) plays a central
role in the adaptive response of hepatic metabolism to the energy re-
quirements characterizing the different reproductive stages [1e3]. In
addition, this receptor was reported to have a key role in the control of
lipid and amino acid (AA) metabolism [1,4]. Unlike in females, the
expression of ERa in the adult male liver is very low [2,4], suggesting
that, in males, the role of this receptor in metabolic control might be
extremely limited. In view of its prominent role in the female liver, ERa
action might strongly contribute to the well-recognized, but often
overlooked, hepatic sexual dimorphism [5e7] and to the sex-speciﬁc
incidence of hepatic diseases [8,9]. Among them, non-alcoholic fatty
liver disease (NAFLD), a syndrome characterized by excess triglyceride
accumulation within hepatocytes [10], represents a paradigmatic
example. Indeed, although obesity is prevalent in females, fertile women
result to be, to some extent, protected from obesity-associated fatty
liver/NAFLD and cardio-metabolic consequences [11e13], suggesting
the involvement of estrogen signaling. This idea is further supported by
studies showing that the lack of estrogens (ovariectomized, OVX, and
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steatosis. However, the analysis of the lack of estrogen signaling in OVX,
ArKO, and ERaKOmice did not allow to disentangle the systemic effects
of estrogens from those occurring in the liver speciﬁcally, preventing the
understanding of the contribution of hepatic estrogen signaling to the
sex-speciﬁc prevalence of fatty liver/NAFLD.
Considering that, in fertile females, estrogens, acting through the
hepatic ERa, might antagonize liver lipid deposition, we hypothesized
that the low content of ERa and the lack of such a well-tuned regu-
lation in males might be at the basis of the higher prevalence of hepatic
steatosis/NAFLD in males, particularly under an unbalanced dietary
regimen. Indeed, although the contribution of liver ERa in preventing or
limiting the diet-induced hepatic steatosis/NAFLD in the two sexes has
not been investigated, this hypothesis is supported by recent reports
highlighting the negative correlation between hepatic ERa expression/
activity and fatty liver [1,20,21].
Thus, the present study was undertaken to evaluate the extent to
which the hepatic ERa might account for sex differences in the ability
of the male and female liver to cope with an excess of dietary lipids and
counteract the development of fatty liver/NAFLD in a model of diet-
induced obesity.ical Sciences, University of Milan, Italy 3Center of Excellence on Neurodegenerative
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Original ArticleThe data obtained show that, besides its sex-biased expression, the
hepatic ERa contributes to the sex-speciﬁc metabolic adaptation to a
fat-enriched diet, accounting for opposite consequences for health in
males and females. This study, by unraveling the relevance of hepatic
ERa in the liver of the two sexes, underlines the necessity to customize
pharmacological and dietary interventions aimed to prevent obesity-
associated fatty liver/NAFLD and the cardio-metabolic consequences.
2. MATERIAL AND METHODS
2.1. Animals
Syngenic (ERa ﬂoxed, ERaf/f) and LERKO (liver ERa knockout) [3] mice
were fed with a low fat diet (LFD, Research diet, D12450B) or a high fat
diet (HFD, Research Diets, D12492) for 16 weeks starting at 4 months
of age. At the end of the experiment, mice were 8 months old. Room
temperature was maintained at 22 Ce25 C, with a 12-hour light/
dark cycle (lights on at 7:00 a.m.). For all the animal studies, both male
and female mice were used. Female mice were collected when in the
Metestrus phase of the estrous cycle; to do this, vaginal smears were
performed at 9:00 a.m. To avoid any possible confounding effect due
to the circadian rhythm or feeding status, the mice were euthanized in
the early afternoon after 6 h of fasting [3]. All animal experimentation
was performed in accordance with the ARRIVE guidelines and the
European guidelines for animal care and the use of experimental an-
imals, approved by the Italian Ministry of Research and University, and
controlled by a departmental panel of experts.
2.2. Liver histology
The left lobe of the liver was ﬁxed in 10% neutral formalin solution
(SigmaeAldrich) overnight at 4 C, cryopreserved in a 30% (w/v)
sucrose solution for 24 h at 4 C, and stored at80 C. Liver sections
7-mm thick were cut with a refrigerated microtome (Leica), collected
on slides, and stored at 80 C until staining. Hematoxylineeosin
(H&E) staining was performed on the frozen slides with Mayer he-
matoxylin (Bio-Optica) for 1 min and, after washing with water, with
1% eosin aqueous solution (Bio-Optica) for 4 min. Oil Red O staining
was performed as previously described [1]. The Accustain Trichrome
stain kit was used for Masson trichrome staining (SigmaeAldrich).
After staining, the slides were cleared in xylenes and cover slipped
with xylene-based mounting medium (Eukitt, Bio-Optica). The liver
sections were evaluated in a blinded fashion under a light microscope.
Semi-quantitative grading of the hepatocellular vacuolar degeneration
and portal inﬂammation (i.e., the inﬁltration of mononuclear inﬂam-
matory cells) was also performed in a blinded fashion. Images of the
stained sections were captured using Microscope Axioscop2 mot plus
(Zeiss).
2.3. Biochemical assays
The triglyceride (TG), free fatty acid (FFA), and cholesterol (CH) levels
were measured with appropriate kits according to the manufacturer’s
protocols (Biovision).
2.4. Metabolomic analysis
For metabolomic analyses, liver tissues were homogenized with a
tissue lyser. Brieﬂy, tissues were lysed in 250 mL of methanol/
acetonitrile 1:1 (v/v) with D-Glucose-13C6 1 ng/mL (internal standard,
Sigma Aldrich, 389374) and centrifuged at 4 C. Supernatant was
saved for subsequent analysis. Amino acid quantiﬁcation was per-
formed through previous derivatization. Samples were incubated with
phenylisothiocyanate (PITC) solution for 20 min at room temperature,
dried, and resuspended in 5 mM ammonium acetate in MeOH/H2O 1:198 MOLECULAR METABOLISM 32 (2020) 97e108  2019 The Author(s). Published by Elsevier GmbH. T(v/v). Metabolomic data were performed on an API-4000 triple quad-
rupole mass spectrometer (AB SCIEX) coupled with a high-
performance liquid chromatography (HPLC) system (Agilent) and a
CTC PAL HTS autosampler (PAL System). The identity of all metabolites
was conﬁrmed using pure standards. Quantiﬁcation of different me-
tabolites was performed with a liquid chromatography/tandem mass
spectrometry (LC-MS/MS) method using a C18 column (Biocrates) for
amino acids and a cyano-phase LUNA column (50 mm  4.6 mm,
5 mm; Phenomenex). The AAs were analyzed through a 10-minute run
in positive ion mode, whereas other metabolites were run for 5 min in
negative ion mode. Twenty multiple reaction monitoring (MRM) tran-
sitions in positive ion mode and 30 MRM transitions in negative ion
mode (all other metabolites) were used, respectively. The mobile
phases for positive ion mode analysis were phase A: 0.2% formic acid
in water and phase B: 0.2% formic acid in acetonitrile. The gradient
was T0 100% A, T5.5min 5%A, and T7min 100%A with a ﬂow rate of
500 mL/min. The mobile phase for negative ion mode analysis (all other
metabolites) was phase A: 5 mM ammonium acetate pH 7.00 in MeOH.
The gradient was 100% A for all the analysis with a ﬂow rate of
500 mL/min. MultiQuant software (version 3.0.2) was used for data
analysis and peak review of chromatograms. Quantitative evaluation of
all metabolites was performed based on calibration curves with pure
standards, and data were normalized on micrograms of proteins.
Metabolomic data analysis was performed using Metaboanalyst 3.0
software (http://www.metaboanalyst.ca/).
Plasma FFA extraction was conducted by Folch method and then as
previously reported [22] using 13C18-labeled linoleic acid and
13C16-
labeled palmitic acid (SigmaeAldrich) as internal standards. Ex-
tracts were dried under nitrogen and resuspended in methanol/
water (1:1) before submission for analyses. For FFA quantiﬁcation,
the MS analysis was conducted with a selective ion monitoring-
tandem mass spectrometry (SIM-MS/MS) method. An electro-
spray ionization (ESI) source was used and connected with an API
4000 triple quadrupole instrument (AB Sciex, USA). The mobile
phases were: water:methanol (97:3)/10 mM isopropylethylamine/
15 mM acetic acid (phase A) and methanol (phase B). T0 20% A,
T20min 1%A, T25min 1%A, T25.1min 20%A, T30min 20%A. The
Hypersil GOLD PFP column (100 mm  2.1 mm, 3 mm) was
maintained at 40 C, and the ﬂow rate was 500 mL/min. Multi-
Quant software version 3.0.2 was used for data analysis and
peak review of chromatograms. The quantitative evaluation of
different FFAs was performed based on standard curves. Quanti-
tative data were normalized on microliter of plasma extracted.
2.5. Real-time PCR gene expression analysis
Total liver RNA extraction was isolated with TRIzol Reagent (Invitrogen)
and puriﬁed using the RNeasy mini-kit protocol (Qiagen), according to
the manufacturer’s instructions. For the preparation of cDNA, 1 mg RNA
was denatured at 75 C for 5 min in the presence of 1.5 mg of random
primers (Promega) in 15 mL ﬁnal volume. Deoxynucleotide triphosphate
(GE Healthcare) and Moloney murine leukemia virus reverse tran-
scriptase (M-MLV RT) (Promega) were added at 0.5mm and 8 U/mL ﬁnal
concentration, respectively, in a ﬁnal volume of 25 mL. The RT reaction
was performed at 37 C for 1 h; the enzyme was inactivated at 75 C for
5 min. Control reactions without the addition of the RT enzyme were
performed for each sample. For the real-time polymerase chain reaction
(rtPCR) experiments, the reaction mix for each sample was made up of
2 mL of pre-diluted cDNA, 5 mL of TaqMan 2 Universal PCRMaster Mix
No AmpErase UNG (ThermoFisher/Life Technologies), 0.5 mL of 20x
primers/probes mix, and 2.5 mL of H2O. The primers used for the rtPCR
reactions are listed in Table S4. The 36b4 primer was used as thehis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1: Hepatic ERa deﬁciency limits HFD-induced lipid accumulation in males. A-B. Histological analysis of the livers of ERaf/f and LERKO males (A) and females (B) fed
with LFD (low fat diet) or HFD (high fat diet) for 16 weeks. Upper, hematoxylin and eosin (H&E) staining; center, Oil Red O staining plus H&E (orange-red: neutral fats; blue: nuclei);
bottom, Masson’s trichrome staining (blue: collagen deposits; red: hepatocyte cytoplasm; dark red-black: nuclei). Magniﬁcations 200. C, F. Quantiﬁcation of the lipid deposits in
the liver tissues of males (C) and females (F) by Oil Red O staining. Data are expressed as percentages of the total section areas. D, G. Triglyceride (TG) content measured in the
liver of male (D) and female (G) mice.E, H. Triglyceride (TG) content measured in the skeletal muscle of male (E) and female (H) mice.Data are presented as mean  SEM. In (C and
F) n ¼ 6; in (D, E, G, H) n ¼ 8-12. p<0.05, p<0.01 and p<0.001 LERKO vs ERaf/f; #p<0.05, ##p<0.01 and ###p<0.001 HFD vs LFD (two-way ANOVA followed by
Bonferroni’s post hoc test).reference gene assay. The reaction was conducted according to the
manufacturer’s protocol using QuantStudio 3 Real-Time PCR System
with the following thermal proﬁle: 2 min at 50 C; 10 min 95 C; 40
cycles (15 s 95 C, 1 min at 60 C). The data were analyzed using the
2DDCt method [23].MOLECULAR METABOLISM 32 (2020) 97e108  2019 The Author(s). Published by Elsevier GmbH. This is an open
www.molecularmetabolism.com2.6. Western blot analysis
Samples of frozen mouse liver were homogenized in ice-cold buffer
(20 mM HEPES, 5 mM MgCl2, 420 mM NaCl, 0.1 mM EDTA, and 20%
glycerol) containing protease and phosphatase inhibitors according to
the manufacturer’s protocols (Phosphatase and Protease Inhibitor Miniaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 99
Original ArticleTablets, Pierce). After three repeated cycles of freezing and thawing,
the homogenate was centrifuged at 16,100 g for 15 min at 4 C, and
the supernatant was collected in a new tube. After appropriate
quantitative analysis (Bradford assay, Pierce), equal amounts of the
protein samples (25 mg of liver extracts) were resuspended in Laemmli
sample buffer and separated in an 8%e10% sodium dodecylsulfate
(SDS) polyacrylamide gel system (Biorad). After transfer, the nitrocel-
lulose membranes were incubated with speciﬁc antibodies overnight at
4 C and then with the secondary antibody conjugated with peroxidase
for 1 h at RT. The primary antibodies used were the following: anti-
LDLR (Novus Biological, NB110-57162), anti-CD36 (Abcam,
ab133625), and anti-b-actin (Sigma, A1978). Immunoreactivity was
detected with an ECL Western Blotting Analysis System (Amersham)
and acquired and analyzed using an Odissey Fc Imaging system and
the Image Studio software (LiCor Biosciences).
2.7. Plasma CH proﬁle
The CH distribution in the plasma lipoprotein fractions was determined
via fast protein liquid chromatography (FPLC) using a Superose 6
column (Amersham Biosciences). Fractions of 500 mL were collected
and assayed for CH with an enzymatic kit (Sentinel).
2.8. Quantiﬁcation and statistical analysis
Statistical analyses were performed by the Student t test for the
comparison of two different experimental groups, or two-way analysis
of variance (ANOVA) followed by the Bonferroni post hoc test for
multiple testing comparisons. All statistical analyses were performed
using GraphPad Prism 5.0 (GraphPad Software). All data are expressed
as mean standard error of the mean (SEM). A p value less than 0.05
was considered statistically signiﬁcant. The statistical parameters can
be found in the ﬁgure legends.
3. RESULTS
3.1. The lack of hepatic ERa signaling has opposite consequences
in the liver of males and females
To study the relevance of hepatic ERa in the response of male and
female livers to an unhealthy, fat-enriched diet, syngenic (ERaf/f) and
liver-speciﬁc ERa knockout (LERKO) [3] mice were fed with a low-fat
diet (LFD) or a 60% high-fat diet (HFD) for 16 weeks starting at 4
months of age (see Methods and Tables S1 and S2). We focused on
that time with the aim to study the sex-speciﬁc relevance of hepatic
ERa in the metabolic adaptation to a diet enriched in fats and in
counteracting lipid accumulation in the liver of the two sexes. At the
end of the dietary treatment, the mice were euthanized in the early
afternoon after 6 h of fasting [3], and the excised livers were processed
for histological and biochemical analysis.
The HFD had a critical effect in ERaf/f males, leading to a major
accumulation of lipids in the liver as shown by Oil Red O staining
(þ280% vs LFD) and by the measurement of TG content (þ395% vs
LFD) (Figure 1A, C, D). Lipid deposition was associated with hepato-
cellular vacuolar degeneration and portal inﬁltration of mononuclear
leukocytes as indicated by H&E and Masson trichrome stainings.
Considering that in the male liver the content of ERa is quite low, we
expected that the liver-speciﬁc ablation of this receptor had minimal
effects in LERKO males with respect to their syngenic counterparts.
Contrary to our expectations was the observation of a moderate lipid
deposition in the liver of LERKO males after a HFD (Figure 1A, C, D).
The effect of both diet and ERa deﬁciency was very different in fe-
males. In ERaf/f females, the HFD did not alter the hepatic lipid content,
whereas the mere ablation of ERa was associated with a signiﬁcant100 MOLECULAR METABOLISM 32 (2020) 97e108  2019 The Author(s). Published by Elsevier GmbH. Tincrease in liver lipid deposition (þ50% TG, irrespective of the diet)
(Figure 1B, F, G).
In males, the HFD also led to lipid accumulation in the skeletal muscle
of both ERaf/f (þ81% vs LFD) and LERKO (þ184% vs LFD). In females,
the HFD enhanced fat deposition in the skeletal muscle of LERKO
(þ162% vs LFD) but not in ERaf/f females (Figure 1EeH). This sug-
gested that, in females, the hepatic ERa plays a role in preventing
ectopic lipid deposition.
In both sexes, the described effects were associated with alterations of
the body weight (BW) that were found to be independent from hepatic
ERa. Indeed, in the course of the experiment, the changes in BW were
superimposable in ERaf/f and LERKO mice (Figure 2A) and, at the end
of the experiment, HFD-fed males and females weighed signiﬁcantly
more than their LFD-fed counterparts (Figure 2B).
The analysis of visceral white adipose tissue (vWAT) weight and feed
efﬁciency (FE) further demonstrated a sex-speciﬁc response to HFD of
ERaf/f and LERKO mice. HFD-fed ERaf/f males accumulated more
vWAT than LERKO males, whereas the opposite was true for females
(Figure 2C). With respect to males, ERaf/f females were able to better
cope with the HFD; indeed, they kept FE relatively low and avoided the
accumulation of fat tissue, an ability lost by LERKO females
(Figure 2CeD). Differently from females, hepatic ERa deﬁciency in
males limited FE after a HFD (24% vs ERaf/f males) (Figure 2D).
Nevertheless, the increased food intake (þ15%) (Figure 2E) suggested
an altered nutrient absorption and/or metabolism in LERKO males.
These data demonstrate that hepatic ERa action accounts for a sex-
speciﬁc response to a HFD with different consequences for males
and females, suggesting that, besides its dimorphic expression
(Fig. S1), liver ERa exerts different metabolic functions in the two
sexes.
3.2. HFD unmasks the sex-speciﬁc impact of hepatic ERa ablation
on liver metabolome
To better comprehend the different roles exerted by ERa in the liver of
the two sexes, we pursued our characterization of liver metabolism
through a metabolomic approach. As shown in the heatmap of
Figure 3A, the most relevant liver metabolites (Table S3) were affected
by the diet and by the presence/absence of hepatic ERa in a sex-
speciﬁc fashion. The principal component analysis (PCA) of liver me-
tabolites clearly showed that the diet acts as a clear discriminating
factor for LERKO males, but less for ERaf/f males that, conversely, are
represented by partially superimposing ellipses (Figure 3B). In females,
the overlap among the four groups indicated that the liver metabolome
of females was less affected by the diet and by ERa deﬁciency
(Figure 3C). Cluster analysis performed on liver metabolites (Figure 3D)
clearly showed how the ablation of ERa in the liver of males is
responsible for a metabolic signature that signiﬁcantly diverged from
that of all other experimental groups. HFD led to major changes in
LERKO males: after the HFD, the metabolic ﬁngerprint of LERKO males
became more similar to that of the HFD-fed females, indicating that the
hepatic ERa directs the male-speciﬁc response to a fat-enriched diet.
By considering a fold change jFCj> 1.5 and aeLog10(p-value)> 1.3,
we found that, in the liver of ERaf/f males, HFD led to a signiﬁcant
decrease in the content of AA (in red) and of short-chain acyl-carnitine
(C4) and to a greater content of medium-chain acyl-carnitines (C8 and
C9) (Figure 4A and table S3). The lack of ERa by itself induced a
metabolic rewiring in the liver of LERKO males, which showed low
content of AA, intermediates of glycolysis/gluconeogenesis (Gly/Gln:
glucose, glucose-6-phosphate, fructose-1,6-biphosphate, lactate),
pentose phosphate pathway (PPP: erythrose-4-phosphate), and high
content of intermediates of TCA cycle (acetyl-CoA, citrate, isocitrate, 2-his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: Effect of HFD and hepatic ERa deﬁciency on body weight and food intake. A. Body weight (BW) of ERaf/f and LERKO mice measured weekly along the 16 weeks
long experiment and expressed as percentage versus time 0. B. BW of ERaf/f and LERKO mice measured at the end of the 16 weeks long experiment. C. Quantiﬁcation of the
visceral white adipose tissue (vWAT) normalized over the BW. D. Feeding efﬁciency expressed as dBW/dFI (dBody weight/dFood intake). E. Food intake (FI) expressed as kcal %.
Data are presented as mean  SEM (n ¼ 18). p<0.05, p<0.01 and p<0.001 LERKO vs ERaf/f; #p<0.05, ##p<0.01 and ###p<0.001 HFD vs LFD (two-way ANOVA
followed by Bonferroni’s post hoc test).oxoglutarate) and energy metabolism [oxidized nicotinamide adenine
dinucleotide (NADþ), reduced nicotinamide adenine dinucleotide
(NADH), oxidized nicotinamide adenine dinucleotide phosphate
(NADPþ), and reduced nicotinamide adenine dinucleotide phosphate
(NADPH)]. The already low content of AA further decreased in the liver
of LERKO males after HFD; this change was associated with a decrease
of intermediates of Gly/Gln (PEP, pyruvate), TCA cycle (acetyl-CoA,
isocitrate, 2-oxoglutarate, succinyl-CoA, succinate), lipid synthesis
(malonyl-CoA), and energy metabolism [NADþ, NADH, NADPþ,
NADPH, adenosine triphosphate (ATP), adenosine diphosphate (ADP),
and adenosine monophosphate (AMP)] and with an increase of short-
(C4) and medium-chain (C8, C9) acyl-carnitines.
In ERaf/f females, the effect of the HFD was circumscribed to a few
changes (low content of glucose-6-phosphate, Ribu-5P, citrate, iso-
citrate, fumarate, and malate) and, differently from males, did not
affect the AA content. AA homeostasis in females was dependent on
hepatic ERa; indeed, compared with ERaf/f females, LERKO females
showed higher content of AA, some of which [alanine (Ala), threonine
(Thr), glutamine (Gln), glutamate (Glu), methionine (Met), histidine
(His), and arginine (Arg)] were signiﬁcantly decreased after a HFD
together with some intermediates of the TCA cycle (isocitrate, 2-
oxoglutarate, succinate, fumarate, malate) and of energy metabolism
(NADPþ, NADPH).
A more detailed analysis based on the pathways with the most relevant
impact (impact > 0.6 and eLog(p-value) > 3) indicated that the
metabolism of AA and, in particular, of branched-chain AA (BCAA: Val,
Leu, Ile) was the most affected by the lack of hepatic ERa and by the
nutritional challenge, especially in males (Figure 4B). Interestingly, onlyMOLECULAR METABOLISM 32 (2020) 97e108  2019 The Author(s). Published by Elsevier GmbH. This is an open
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when challenged with a HFD, a feature associated with a healthy
metabolic phenotype.
3.3. The lack of hepatic ERa in males, but not females, is
responsible for an altered plasma lipid proﬁle
Next, we examined the extent to which the lack of hepatic ERa could
affect the homeostasis of circulating lipids (TG, FFA, and CH), partic-
ularly under a HFD regimen.
As shown in Figure 5A, plasma TG levels were slightly increased by a
HFD in males but not in females, a sex-speciﬁc effect that resulted
independently from hepatic ERa presence/absence.
With the exception of docosahexaenoic acid (DHA, 40%), the levels
of FFA were unchanged by HFD in the plasma of ERaf/f males
(Figure 5B). In males, this homeostasis was ensured by hepatic ERa;
indeed, the lack of this receptor in LERKO males led to a signiﬁcant
increase (or showed a trend to augment) in the majority of FFA, an
effect boosted by the HFD (Figure 5B). In ERaf/f females, the only
signiﬁcant changes driven by HFD were related to stearic acid (þ48%)
and to DHA (41%), whereas no changes were observed in LERKO
females independent of the diet (Figure 5C). These data suggest that
the hepatic ERa deﬁciency impacts on the metabolism of FFA mainly in
males.
Having found that hepatic ERa plays a pivotal role in the regulation
of CH and lipoprotein metabolism in females [2], we pursued our
study by measuring total CH levels and by analyzing the distribution
of CH among plasma lipoproteins by fast protein liquid chroma-
tography (FPLC) (Figure 6AeD). HFD induced a signiﬁcant increaseaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 101
Figure 3: HFD unmasks the sex-speciﬁc impact of hepatic ERa ablation on liver metabolome. A. Hierarchical Clustering Heatmap of biologically major metabolites of the
glycolysis/gluconeogenesis (GLY/GNG), pentose phosphate pathway (PPP), tricarboxylic acid cycle (TCA), energy metabolism (En. Met.), amino acids (AA), and acyl-carnitines (Acyl-
Carn) measured in the liver. The color-coded scale on the left indicates the normalized metabolite expression. B-C. Principal Component Analysis (PCA) of the metabolites
measured in the liver of ERaf/f and LERKO males (B) and females (C) fed with LFD and HFD. Colored ellipses - generated using MetaboAnalyst 3.0 software - represent 95%
conﬁdence intervals and highlight the basic clustering/separation between groups. Colored dots represent individual samples (n¼6). D. Hierarchical Clustering (Dendrogram) of the
data showed in A was done using a software available at the web page http://www.wessa.net/rwasp_hierarchicalclustering.wasp.
Original Articleof total CH levels in the plasma of ERaf/f but not in LERKO males,
whereas the opposite was true for females (Figure 6A). As a
consequence of the HFD, the distribution of CH in the low-density
lipoprotein (LDL) fraction increased, leading to a higher LDL/high-
density lipoprotein (HDL) ratio in both ERaf/f males and females
(Figure 6BeD). The sole ablation of liver ERa resulted in higher
LDL-CH and LDL/HDL ratio in both LERKO males and females.
However, only in LERKO males LDL-CH and LDL/HDL ratio were
further augmented by HFD, whereas no changes were observed in
LERKO females after HFD (Figure 6BeD), despite the higher total
CH levels (Figure 6A). All together, these data suggest that ERa
action in the liver strongly contributes to the different, sex-speciﬁc102 MOLECULAR METABOLISM 32 (2020) 97e108  2019 The Author(s). Published by Elsevier GmbH. Tregulation of circulating lipids (FFA and CH, in particular) in
response to a fat-enriched diet.
3.4. Liver ERa regulates the hepatic lipid metabolism in a sex-
speciﬁc fashion
Lipid deposition in the liver might be a consequence of an imbalance
between the lipids that are taken up or synthesized de novo and those
being catabolized or exported [24]. The fact that the lack of hepatic
ERa prevented lipid deposition in the liver and increased the circulating
lipids in males, but did the opposite in females, led us to hypothesize
that the ERa action may regulate the uptake of lipids differently in the
two sexes. To investigate on that, we ﬁrst evaluated the expression ofhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 4: Hepatic ERa preserves AA homeostasis in the liver of females but not of males challenged with HFD. A. Volcano plot of biologically relevant metabolites
measured in the liver of ERaf/f and LERKO males and females fed with LFD and HFD. Only metabolites with a |FC|>1.5 and -Log10(p-value)>1.3 were considered as signiﬁcant and
displayed with triangles of different colors depending on the class they belong to (see legend). B. Pathway impact analysis of the biological pathways regulated in the liver of ERaf/f
and LERKO males and females fed with LFD and HFD. Only metabolic pathway with an impact>0.6 and a -Log(p-value)>3 were considered as signiﬁcant and displayed as colored
circles (varying from yellow to red).
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Figure 5: Lack of hepatic ERa affects the circulating lipids especially in males. A-C. Levels of triglyceride (TG) (A) and free fatty acid (FFA) (B-C) measured in the plasma.
Data information: In (AeC), data are presented as mean  SEM (n¼ 8-12). p<0.05, p<0.01 and p<0.001 LERKO vs ERaf/f; #p<0.05, ##p<0.01 and ###p<0.001 HFD
vs LFD (two-way ANOVA followed by Bonferroni’s post hoc test).
Original Articlereceptors relevant for the uptake of lipids, such as low-density lipo-
protein receptor (LDLR) and cluster of differentiation 36 (CD36). LDLR
and CD36 were induced in the liver of ERaf/f but not LERKO males
when exposed to HFD, indicating that, in the absence of hepatic ERa,
the male liver lost its ability to promote the lipid uptake (Figure 6EeG).
Compared with their male counterparts, ERaf/f and LERKO females
showed high basal Ldlr and Cd36 mRNAs and followed a different
strategy when exposed to HFD: the lipid uptake was unchanged in the
liver of ERaf/f females (Figure 6EeG) and promoted in the liver of
LERKO females (þ103% CD36, Figure 6G). These data suggest that
ERa might have a sex-speciﬁc role in the control of lipid uptake in
response to HFD.
The hepatic content of LDLR [25,26] and CD36 [27] can be
regulated through the degradation promoted by proprotein con-
vertase subtilisin/kexin type 9 (PCSK9), whose expression is
affected by estrogens [28]. Pcsk9 mRNA was upregulated by HFD
in the liver of ERaf/f but not in LERKO males, whereas the
opposite was true for females (Figure 6H). Although its relevance
in the mouse liver is still debated [29e31], inducible degrader of
the low-density lipoprotein receptor (IDOL), the expression of
which is controlled at the transcriptional level by liver X receptor
alpha (LXRa), may mediate the degradation of LDLR, thereby
limiting the uptake of CH through the LDLR pathway. The over-
expression of Idol (þ32%) and Lxra (þ29%) in the liver of
LERKO males treated with HFD suggested that the low expression
of LDLR protein might be a consequence of an enhanced LDLR
degradation due to the over-activation of the LXRa-IDOL pathway
(Figure 6H). Interestingly, such regulation was found to be male-
speciﬁc, as we did not observe a similar impairment of the
modulation of LDLR and of Idol expression in the liver of females
(Figure 6F,H).104 MOLECULAR METABOLISM 32 (2020) 97e108  2019 The Author(s). Published by Elsevier GmbH. TNext, we evaluated the relevance of sex and hepatic ERa in the
regulation of lipid metabolism by measuring the changes in the
expression of some key genes involved in: i) the synthesis of FA (Fasn,
fatty acid synthase; Elovl6, ELOVL fatty acid elongase 6) and CH
(Hmgcr, 3-hydroxy-3-methylglutaryl-CoA reductase; Pmvk, phospho-
mevalonate kinase); ii) generation of lipid droplets (Plin2, perilipin-2);
iii) mitochondrial FA b-oxidation (mtFAO: Cpt1a, carnitine palmitoyl-
transferase 1A; Hadha, hydroxyacyl-Co A dehydrogenase trifunctional
multienzyme complex subunit alpha, and Acadl, acyl-CoA dehydro-
genase long chain); and iv) conversion of CH into bile acids (Cyp7a1
and Cyp27a1,cytochrome P450 7A1 and P450 27A1); v) esteriﬁcation,
assembly, and export of lipids (Acat2, acetyl-CoA acetyltransferase 2;
Mttp, microsomal triglyceride transfer protein) (Figure 7).
In ERaf/f males, HFD feeding was associated with an increased lipid
synthesis (þ188% Fasn, þ21% Elovl6, þ158% Hmgcr, þ76% Pmvk
vs LFD) and with the generation of lipid droplets (þ66% Plin2 vs LFD),
thus contributing to lipid accumulation in the liver (Figure 7). The
mtFAO (þ35% Cpt1a, þ35% Hadha, þ39% Acadl vs LFD) and the
catabolism of CH (þ73% Cyp7a1 and þ37% Cyp27a1 vs LFD) were
increased by HFD. However, mtFAO was found to be inefﬁcient, leading
to the accumulation of medium-chain acyl-carnitines (Figure 3A and
Table S3) that, in turn, could further promote the degeneration of
hepatic tissue. In the attempt to manage lipid excess, the male liver
promoted the export of lipids by enhancing the expression of Acat2
(þ115% vs LFD) and Mttp (þ22% vs LFD), a metabolic adaptation that
might contribute to the high levels of TG and CH measured in the
plasma (Figures 5A and 6A). These data suggested that the fat
deposition in the liver of ERaf/f males might be a consequence of
increased import and synthesis of lipids and altered mtFAO.
In the liver of LERKOmales, the synthesis of lipids was increased, although
to a lesser extent with respect to ERaf/f males (99% Fasn, 119%his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 6: Lack of hepatic ERa in males leads to an impaired cholesterol proﬁle. A. Levels of cholesterol (CH) measured in the plasma. B. Representative proﬁle of the total
CH content in the fractions of plasma separated by fast performance liquid chromatography (FPLC). C. Analysis of CH distribution in VLDL (very-low density lipoprotein), LDL (low
density lipoprotein), HDL (high density lipoprotein) fraction in the plasma of ERaf/f and LERKO males and females was done by integrating the area under the curve (AUC) of the CH
proﬁles showed in B. D. Ratio between the LDL-CH and HDL-CH fraction values calculated as in C. E. mRNA contents of Ldlr (low-density lipoprotein receptor) and Cd36 (cluster of
differentiation 36) measured in the liver by rtPCR. F-G. Representative western blotting analyses and semi-quantitative analyses of the contents of LDLR (F) and CD36 (G) in liver
extracts. H. mRNA content of Pcsk9 (proprotein convertase subtilisin/kexin type 9), Idol (inducible degrader of the LDLR) and Lxra (liver X receptor alpha) measured in the liver by
rtPCR. Data are presented as mean  SEM: in (AeD), n ¼ 8-12; in (E, H), n ¼ 8-12; in (F, G), n ¼ 6. p<0.05, p<0.01 and p<0.001 LERKO vs ERaf/f; #p<0.05, ##p<0.01
and ###p<0.001 HFD vs LFD (two-way ANOVA followed by Bonferroni’s post hoc test).Hmgcr vs ERaf/f males). The HFD regimen induced the FA catabolism, as
suggested by the upregulation of Cpt1a, Hadha, Acadl, and the 54%
reduction of malonyl-CoA (Figure 3A and Table S3), a powerful inhibitor of
mtFAO [32]. The reduced uptake and synthesis of CH was associated with
a restrained induction of CH catabolism and esteriﬁcation with respect to
ERaf/f males (26% Cyp7a1, -25% Cyp27a1 and -51% Acat2 vs ERaf/fMOLECULAR METABOLISM 32 (2020) 97e108  2019 The Author(s). Published by Elsevier GmbH. This is an open
www.molecularmetabolism.commales) and with unchanged values ofMttp. These data suggested that the
limited fat deposition in the liver and the altered levels of lipids in the
plasma of LERKO males were a consequence of a limited import and
synthesis of lipids (Figure 7).
Under a HFD feeding regimen, the liver of ERaf/f females inhibited de
novo lipogenesis (DNL) (43% Fasn, 72% Elovl6 vs LFD), preventedaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 105
Figure 7: Hepatic ERa confers on liver a sex-speciﬁc strategy to cope with the excess of dietary lipids. Heatmaps representing the HFD-induced changes in the hepatic
content of key genes involved in lipid metabolism. Data are expressed as percentage versus LFD.
Original Articlethe synthesis of CH, and promoted the catabolism of FA (þ41%
Hadha,þ37% Acadl vs LFD) and the catabolism of CH (þ84% Cyp7a1
and þ34% Cyp27a1 vs LFD), without leading to an accumulation of
medium-chain acyl-carnitines (Figure 3A and Table S3). The lipid
export was unchanged. All together, these changes represented a
concerted metabolic strategy useful to counteract the development of
fatty liver and the rise of circulating lipids (Figure 7).
This female-biased ability to counteract the excess of dietary lipids by
adopting protective metabolic adjustments was, at least in part,
dependent on hepatic ERa (Figure 7). Indeed, with the lack of hepatic
ERa, although the synthesis of FA was still inhibited DNL (43%
Fasn, 67% Elovl6 vs LFD), the synthesis of CH increased (þ58%
Hmgcr, þ36% Pmvk vs LFD). mtFAO was increased by HFD but to a
lesser extent with respect to ERaf/f females (19% of Hadha and
Acadl vs ERaf/f females) and led to the accumulation of medium- (C8,
C9, C10) and long-chain (C12, C16, C8 and C18:1) acyl-carnitines
(Figure 3A and Table S3). The lack of hepatic ERa did not affect the
expression of genes involved in CH catabolism nor in lipid export
(Figure 7). These changes suggested that the increased lipid import,
the enhanced CH synthesis, and the impaired mtFAO might contribute
to higher deposition of lipids in the liver and to higher CH levels in the
plasma of LERKO females.
These data led us to conclude that hepatic ERa contributes to the sex-
speciﬁc metabolic adaptation to a diet enriched in fats, by favoring and
preventing lipid deposition in the liver of males and females,
respectively.
4. DISCUSSION
By directly comparing siblings of the two sexes, we here underline
major, sex-speciﬁc, and ERa-dependent differences in male and fe-
male liver ability to cope with an excessive dietary intake of fats. The106 MOLECULAR METABOLISM 32 (2020) 97e108  2019 The Author(s). Published by Elsevier GmbH. Tmale liver was unable to set up compensatory mechanisms to deal
with the excess of dietary lipids in the long-term: after 16 weeks of
HFD, enhanced lipid uptake, increased lipid synthesis, and impaired FA
oxidation led to fatty liver and degeneration of hepatic metabolism,
which favored the increase of circulating CH. On the contrary, female
liver was able to manage the excess lipids, limiting lipid import,
avoiding worthless DNL, and efﬁciently promoting the mtFAO. Such
female metabolic ﬂexibility was possibly a consequence of a sex-
biased hepatic metabolism geared to satisfy the energy needs of
reproduction [5]. Indeed, the necessity to adapt the hepatic metabolism
to different and highly variable reproductive needs might provide the
female liver with a greater ability to manage dietary stress, including
lipid excess. In females, this metabolic ﬂexibility was dependent on
hepatic ERa; indeed, LERKO females were unable to properly process
dietary lipids and were affected by fatty liver, increased circulating
lipids, and ectopic fat accumulation, all metabolic alterations generally
occurring in females after menopause or ovariectomy [1,33,34].
Since hepatic ERa activity provides females with the metabolic ﬂexi-
bility necessary to antagonize the detrimental effects of a HFD, the
ﬁnding of major metabolic changes in LERKO males was quite unex-
pected. Indeed, despite the low expression of ERa that led us to
speculate that this receptor might be less relevant for the male hepatic
metabolism, our results showed the opposite: the lack of hepatic ERa
in LERKO males prevented lipid deposition and the progressive
degeneration of hepatic tissue typical of ERaf/f males exposed to HFD.
Therefore, despite its abundance, ERa accomplishes a signiﬁcant
metabolic function in the male liver that is clearly not the same as in
females. This is particularly relevant with regard to the uptake and de
novo synthesis of lipids; indeed, under HFD conditions, the regulation
of genes involved in these metabolic pathways is diametrically
opposed in the liver of males and females, depending on the presence/
absence of hepatic ERa.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Besides lipid catabolism, the hepatic content of AA (Figure 6AeB) was
the pathway most affected by HFD regimen in ERaf/f males, conﬁrming
studies showing a correlation between low AA content and hepatic
steatosis/NAFLD in obesogenic-like conditions [35]. The ﬁnding that
the content of AA was decreased by HFD both in LERKO males and
females, whereas it was unaffected in the liver of ERaf/f females,
suggested that the homeostasis of AA under an unbalanced dietary
regimen is a female-speciﬁc prerogative in charge of hepatic ERa.
However, the lack of hepatic ERa did not decrease but, otherwise,
increased the differences between the two sexes (Fig. S2), suggesting
that ERa might strongly contribute to a different regulation of the
hepatic metabolism in the two sexes.
How can we explain that the same receptor in the same tissue has a
different function in the two sexes? In our previous reports, we showed
that sex differences in the hepatic metabolism (and in particular in the AA
content) depend on an estrogen-dependent sexual differentiation of the
male liver that occurs right around birth; at that time, testis-derived
testosterone is converted by the aromatase enzyme in estrogen that
“organizes” and programs the liver in a male-speciﬁc manner, by acting
through hepatic ERa [4]. The lack of such “organization” in the liver of
LERKO males (that do not express hepatic ERa since embryonal day 18.5)
might be responsible for a major metabolic rewiring of the liver, even
when LERKO males are exposed to LFD (Figures 3A and 4A). As a
consequence of the lack of ERa-dependent programming of male hepatic
metabolism, the metabolic response of the LERKO male liver to HFD
regimen was clearly different from that of the ERaf/f male liver and the
LERKO female liver. In this view, liver ERa also has speciﬁc abilities in
controlling hepatic metabolism in males, despite its low concentration.
5. CONCLUSION
This study highlights the essential role of hepatic ERa in the opposite
regulation of lipid metabolism in the liver of the two sexes when dietary
lipids are in excess: in males, hepatic ERa action contributes to liver
lipid accumulation mainly by stimulating lipid import and synthesis;
conversely, in females, ERa prevents the hepatic lipid deposition by
keeping the lipid uptake low, by inhibiting lipid synthesis, and by
efﬁciently promoting mtFAO.
All together, these data led us to conclude that hepatic ERa strongly
contributes to the sex-speciﬁc response to a diet enriched in fats, and
its action accounts for opposite consequences for hepatic health in
males and females. In view of our observations, a proper liver ERa
activity should be preserved in females to maintain the metabolic
ﬂexibility and counteract the metabolic impairments (fatty liver,
increased circulating lipids) typical of the post-menopause period
[1,33,34]. As the exposure to estrogenic compounds early in life may
have severe consequences for the hepatic metabolism of males [4],
our study questions whether the increased incidence of metabolic
disturbances may be associated with an early exposure to estrogen-
like endocrine disruptors [36,37], whose abundance is continuously
growing as a result of contaminants of our environment.
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